Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.88 | 38.45 |
PEG Ratio (TTM) | -0.03 | 1.18 |
P/S Ratio (TTM) | 2.47 | 7.08 |
P/B Ratio (TTM) | 0.28 | 1.63 |
P/FCF Ratio (TTM) | 5.12 | 26.18 |
Price to 5YR AVG Earnings Ratio | N/A | 125.89 |
Price to 5YR AVG FCF Ratio | N/A | 93.99 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -25.86% | 5.31% |
ROE (TTM) | -29.80% | 0.74% |
Net Profit Margin (TTM) | -281.18% | 10.47% |
ROIC 5YR AVG | N/A | 11.81% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -8.58% | -1,811.54% | N/A |
Revenue | -13.17% | 309.71% | N/A |
Net Income | -11.57% | -2,893.34% | N/A |
Cash Flow | -37.85% | 173.72% | N/A |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.10 | 1.73 |
Quick Ratio (TTM) | 2.03 | 1.29 |
D/E Ratio (TTM) | 0.01 | -0.85 |
Interest Coverage (TTM) | -605.95 | 2.21 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | 0.25 | 12.67 |
LTL to 5YR AVG FCF | N/A | 3.37 |
Shares Outstanding Growth 5YR AVG | N/A | 1.32% |